Windmill Closes $12.0M Seed

wet hydration

Wet hydration is your everyday upgrade. Hydration that does more, tastes better, and moves with you. IG & TikTok:@wethydration

Kore.ai

Kore.ai, a leader in enterprise AI, accelerates business outcomes from AI with agentic AI applications built on the industry-leading Kore.ai Agent Platform. Its growing catalogue includes pre-built solutions for banking, healthcare, and retail; horizontal applications for IT, HR, and recruiting; and marketplace that help enterprises deploy AI agents quickly across additional industries and use cases. Open and agnostic by design, Kore.ai gives organizations flexibility in choosing AI models, cloud infrastructure, and enterprise systems. Trusted by nearly 500 Global 2000 companies, Kore.ai enables secure, scalable AI adoption worldwide. With its roots grounded in the Enterprise, Kore.ai brings years of experience in AI applications for customer service, workplace productivity and process automation. The company has a strong patent portfolio in the AI space and has been recognized as a leader and an innovator by top analysts. Headquartered in Orlando, Kore.ai has a network of offices to support customers in India, the UK, the Middle East, Japan, South Korea, and Europe. Visit Kore.ai to learn more.

Hedges

Hedges helps companies lock in their margins by turning volatile diesel costs into a fixed line item.

Ridge Bio

Ridge Biotechnologies is pioneering AI-based enzyme and targeted drug design to power the next wave of precision therapeutics. Led by a collection of established biotech entrepreneurs and faculty from top institutions, we use proprietary machine learning models informed by high-throughput cell-free experimentation for a wide range of applications in antibody-drug conjugates (ADCs), conditionally active prodrugs, in vivo CART therapies, targeted nucleic acid delivery, radiotherapies, and enzyme-based therapeutics. Our current product lines include NativeLink enzymes that enable precision bioconjugation including construction of ADCs and Antibody-oligonucleotide conjugates, ProTrigger linkers that provide tissue and disease-specific activation and release of diverse payloads and prodrugs, and new classes of enzyme-based Catalytic Medicines. We are focused on enabling our partners to build better drugs for patients.

Betterness

Smarter Wellness, Better You. Launching Q2 2025.